Emcure Pharmaceuticals Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 77.82% of Emcure Pharmaceuticals, FIIs hold 4.94%, DIIs hold 8.49% and the public holds 8.75%. Promoter holding fell by 0.01 percentage points from Jun 2026.
Get an alert when Emcure Pharmaceuticals reports results or its shareholding changes. Free account.
Promoters
77.82%
−0.01 pp QoQ
FIIs
4.94%
+0.07 pp QoQ
DIIs
8.49%
+0.03 pp QoQ
Public
8.75%
−0.09 pp QoQ
Emcure Pharmaceuticals shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 77.82% | 4.94% | 8.49% | 8.75% | 1,29,328 |
| Jun 2026 | 77.83% | 4.87% | 8.46% | 8.84% | 1,24,991 |
| Mar 2026 | 77.87% | 3.35% | 6.10% | 12.69% | 1,22,189 |
| Dec 2025 | 77.87% | 3.59% | 6.10% | 12.43% | 1,18,863 |
| Sep 2025 | 77.88% | 3.29% | 4.36% | 14.46% | 1,26,169 |
| Jun 2025 | 77.92% | 2.86% | 2.84% | 16.39% | 1,33,549 |
| Mar 2025 | 77.92% | 3.06% | 3.44% | 15.58% | 1,39,671 |
| Dec 2024 | 77.94% | 3.05% | 3.87% | 15.15% | 1,43,449 |
| Sep 2024 | 78.08% | 2.91% | 3.96% | 15.05% | 1,52,914 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹44.76k cr, the promoter group's 77.82% stake is worth ₹34.83k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Emcure Pharmaceuticals shareholding: common questions
What is the promoter holding in Emcure Pharmaceuticals?
Promoters hold 77.82% of Emcure Pharmaceuticals as of Sep 2026. Their stake fell by 0.01 percentage points from Jun 2026.
How much do FIIs hold in Emcure Pharmaceuticals?
Foreign institutional investors (FIIs) held 4.94% of Emcure Pharmaceuticals in Sep 2026, +0.07 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Emcure Pharmaceuticals?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 8.49% of Emcure Pharmaceuticals in Sep 2026, +0.03 pp versus Jun 2026.
Is the promoter holding in Emcure Pharmaceuticals pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Emcure Pharmaceuticals.
How has Emcure Pharmaceuticals's promoter holding changed in the last year?
Promoter holding moved from 77.88% in Sep 2025 to 77.82% in Sep 2026 (−0.06 pp).
How many shareholders does Emcure Pharmaceuticals have?
Emcure Pharmaceuticals had 1,29,328 shareholders in Sep 2026, compared with 1,24,991 in Jun 2026.